|
Market Closed -
Nasdaq
01:30:00 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.90 USD | -0.73% |
|
+1.40% | +77.24% |
| 10/07 | Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 15/05 | ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
ICCC 10.90 $
-0.73%
5L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ICCC | 10.90USD | -0.73% | 5L $ | |
CBOE
| ICCC | 11.10USD | +4.57% | 1.11T $ | |
|
Deutsche Boerse AG
| IUL | 9.350EUR | -1.06% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 11.72 | 11.72 | 11.21 |
| Spread/Res. | -7.00% | -7.00% | -2.77% |
| Spread/Supp. | +8.35% | +35.40% | +49.32% |
| Support | 10.06 | 8.05 | 7.3 |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
Select your edition
All financial news and data tailored to specific country editions
